THOUGHTFUL TANGENTS · THOMAS BECK, MD
What the ADHD Life Expectancy Study Actually Shows
August 5, 2026
ADHD gets a lot of coverage, some of it useful and some of it alarming. It is hard to tell which is which. When a study or a headline is worth your attention, we will read it closely and tell you what it means for your care. We will leave out the hype and give you the part that matters.
We are starting with a study that made real news, because it deserves a careful read.
The finding
Researchers used records from nearly 800 UK primary care practices. They followed more than 30,000 adults diagnosed with ADHD and compared them to over 300,000 matched peers. It is the largest study of its kind, and the first to estimate life expectancy from actual mortality data rather than prediction.
Adults with diagnosed ADHD died earlier than their peers. The gap was about 6.8 years for men and 8.6 years for women. Death rates were roughly double.
What it does not mean
That number is not a personal forecast. It is an average drawn from a specific population, and the population matters.
Only about 0.3% of adults in the UK database had a recorded ADHD diagnosis. The true prevalence of ADHD in adults is closer to 2 to 4%. That means the people captured in this study are not a random sample of everyone with ADHD. They are the fraction who were impaired enough, or complicated enough, to get diagnosed in a system that historically underdiagnoses the condition. The cohort skews toward more severe presentations with more comorbidity. Your personal risk profile is almost certainly different from the group average.
What it does mean
The researchers did not attribute the gap primarily to accidents or impulsivity, which is what most people assume about ADHD risk. The leading causes of death were the same ones that affect everyone: cardiovascular disease, metabolic disease, respiratory illness. The difference was in how often they occurred and how early.
That points to a mechanism that matters. ADHD is a disorder of self-regulation. Self-regulation quietly shapes sleep, diet, exercise, medication adherence, follow-through on medical advice, and the ability to act on health information even when you know what the right choice is. Decades of small effects in those areas compound into the kind of gap this study measured.
That is actually the less frightening reading. If the gap were driven by causes you could not influence, it would be a prognosis. Because it is driven substantially by modifiable health behaviors, it is a target.
What I would pay attention to
The study also found higher rates of anxiety and depression in the ADHD group, and those conditions were associated with higher mortality. This is consistent with what we see clinically. Mood and anxiety symptoms in ADHD are common, treatable, and often undertreated because the focus stays on attention.
If your mood or anxiety has been heavy lately, tell your care team. You do not need to wait for your next visit to raise it.
For the women reading this
The gap was larger for women, by roughly two years. That likely reflects years of ADHD being missed in women and treated as something else. It is part of why Terry Noyes, PA-C, is developing our care for women specifically, including the hormonal shifts that can make symptoms worse.
The takeaway
The honest summary is not that these years are lost by default. They are lost to causes we can often do something about. That makes this a study about prevention, not fate.
None of this asks you to be perfect. It asks you to keep working the parts that are yours, and to let us carry the parts that are ours.
Thomas Beck, MD
Winston Integrative ADHD
Thoughtful Tangents is a blog from Winston Integrative ADHD, written by Thomas Beck, MD. It is not medical advice for your individual situation. If you need clinical support, contact our office directly.